Biovail to Present at JPMorgan Healthcare Conference

January 06, 2010

TORONTO, Jan 06, 2010 (BUSINESS WIRE) -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the 28th Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.

Biovail's presentation is scheduled for Wednesday, January 13, 2010 at 11:00 a.m. PST (2:00 p.m. EST). A live and archived Webcast, in addition to presentation slides, will be available on the Investor Relations page of Biovail's Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.

SOURCE: Biovail Corporation

Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice President, Investor Relations & Corporate Communications